ZimVie Inc.
ZimVie Inc. (ZIMV) Financial Performance & Income Statement Overview
Explore the financials of ZimVie Inc. (ZIMV), including yearly and quarterly data on income, cash flow, and balance sheets.
ZimVie Inc. (ZIMV) Income Statement & Financial Overview
Explore comprehensive income reports for ZimVie Inc. ZIMV, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $112.00M | $111.52M | $103.22M | $116.81M |
| Cost of Revenue | $37.95M | $38.71M | $35.82M | $43.52M |
| Gross Profit | $74.05M | $72.81M | $67.40M | $73.29M |
| Gross Profit Ratio | $0.66 | $0.65 | $0.65 | $0.63 |
| R&D Expenses | $5.37M | $6.62M | $6.93M | $6.58M |
| SG&A Expenses | $58.98M | $58.56M | $57.31M | $62.38M |
| Operating Expenses | $73.27M | $79.14M | $72.24M | $79.98M |
| Total Costs & Expenses | $111.22M | $117.85M | $108.06M | $123.50M |
| Interest Income | $2.04M | $2.11M | $2.47M | $1.97M |
| Interest Expense | $4.05M | $4.12M | $4.83M | $5.07M |
| Depreciation & Amortization | $8.65M | $8.62M | $8.78M | $8.49M |
| EBITDA | $13.16M | $7.14M | $9.87M | $6.78M |
| EBITDA Ratio | $0.12 | $0.06 | $0.10 | $0.06 |
| Operating Income | $780000.00 | -$6.33M | -$4.84M | -$6.69M |
| Operating Income Ratio | $0.007 | -$0.06 | -$0.05 | -$0.06 |
| Other Income/Expenses (Net) | -$331000.00 | $738000.00 | $1.10M | -$91000.00 |
| Income Before Tax | $449000.00 | -$5.59M | -$3.74M | -$6.78M |
| Income Before Tax Ratio | $0.004 | -$0.05 | -$0.04 | -$0.06 |
| Income Tax Expense | $3.07M | $4.08M | -$688000.00 | $2.77M |
| Net Income | -$1.47M | -$11.77M | -$2.28M | -$4.01M |
| Net Income Ratio | -$0.01 | -$0.11 | -$0.02 | -$0.03 |
| EPS | -$0.05 | -$0.43 | -$0.08 | -$0.15 |
| Diluted EPS | -$0.05 | -$0.43 | -$0.08 | -$0.15 |
| Weighted Avg Shares Outstanding | $27.70M | $27.40M | $27.57M | $27.41M |
| Weighted Avg Shares Outstanding (Diluted) | $27.70M | $27.40M | $27.57M | $27.41M |
Over the past four quarters, ZimVie Inc. demonstrated steady revenue growth, increasing from $116.81M in Q2 2024 to $112.00M in Q1 2025. Operating income reached $780000.00 in Q1 2025, maintaining a consistent 1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $13.16M, reflecting operational efficiency. Net income rose to -$1.47M, with EPS at -$0.05. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan